Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction

European Addiction Research

Volumn 14, Issue 1, 2008, Pages 38-46

  Karow, A ^a   Verthein, U ^a   Krausz, M ^a   Schafer I ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Family; Opiate addiction; Quality of Life; Substance abuse

Indexed keywords

ALCOHOL; CANNABIS; DIAMORPHINE; OPIATE; TRANQUILIZER;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; CONFLICT; FAMILY LIFE; FEMALE; HEROIN DEPENDENCE; HUMAN; LEGAL ASPECT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PERSONALITY DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SOCIAL PROBLEM;

ADULT; CONFLICT (PSYCHOLOGY); COUNSELING; FAMILY; FAMILY RELATIONS; FEMALE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PERSONALITY DISORDERS; PERSONALITY INVENTORY; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 38049086787     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110409     Document Type: Article

References (52)

1. Krausz M, Degkwitz P, Kuhne A, Verthein U: Comorbidity of opiate dependence and mental disorders. Addict Behav 1998;23:767-783.
2. Krausz M, Verthein U, Degkwitz P: Psychiatric comorbidity in opiate addicts. Eur Addict Res 1999;5:55-62.
3. Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M: A 12-year follow-up of a methadone medical maintenance program. Am J Addict 1999;8:293-299.
4. Grella CE: Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatment. J Psychoactive Drugs 2003;35(suppl 1):169-179.
5. Healey A, Knapp M, Marsden J, Gossop M, Stewart D: Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey. J Health Serv Res Policy 2003;8:134-141.
6. March JC, Oviedo-Joekes E, Romero M: Drugs and social exclusion in ten European cities. Eur Addict Res 2006;12:33-41.
7. Rogne GS, Myrvang B, Opjordsmoen S: Criminality in drug addicts: a follow-up study over 25 years. Eur Addict Res 2004;10: 49-55.
8. Krupitsky EM, Zvartau EE, Lioznov DA, Tsoy MV, Egorova VY, Belyaeva TV, Antonova TV, Brazhenko NA, Zagdyn ZM, Verbitskaya EV, Zorina Y, Karandashova GF, Slavina TY, Grinenko AY, Samet JH, Woody GE: Comorbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addict Res 2006;12:12-19.
9. Prince PN, Prince CR: Subjective quality of life in the evaluation of programs for people with serious and persistent mental illness. Clin Psychol Rev 2001;21:1005-1036.
10. Longabaugh R, Mattson ME, Connors GJ, Cooney NL: Quality of life as an outcome variable in alcoholism treatment research. J Stud Alcohol Suppl 1994;12:119-129.
11. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657-1664.
12. Bullinger M: Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research. Restor Neurol Neurosci 2002;20:93-101.
13. Ventegodt S, Merrick J: Psychoactive drugs and quality of life. Sci World J 2003;3:694-706.
14. Millson PE, Challacombe L, Villeneuve PJ, Fischer B, Strike CJ, Myers T, Shore R, Hopkins S, Raftis S, Pearson M: Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations. Can J Publ Hlth 2004;95:99-103.
15. Smith KW, Larson MJ: Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse 2003;29:323-335.
16. Giacomuzzi SM, Riemer Y, Kemmler G, Ertl M, Richter R, Rossler H, Hinterhuber H: Subjective wellbeing and somatic markers in methadone substitution: evaluation of 61 heroin addicts. Fortschr Med Orig 2001;119(3-4):103-108.
17. Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J: Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997;92:707-716.
18. Torrens M, Domingo-Salvany A, Alonso J, Castillo C, San L: Methadone and quality of life. Lancet 1999;353:1101.
19. Perneger TV, Giner F, del Rio M, Mino A: Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998;317:13-18.
20. Schaar I, Ojehagen A: Predictors of improvement in quality of life of severely mentally ill substance abusers during 18 months of cooperation between psychiatric and social services. Soc Psychiatry Psychiatr Epidemiol 2003;38:83-87.
21. Vanagas G, Padaiga Z, Subata E: Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas) 2004;40:833-841.
22. Bizzarri J, Rucci P, Vallotta A, Girelli M, Scandolari A, Zerbetto E, Sbrana A, Iagher C, Dellantonio E: Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse 2005;40:1765-1776.
23. Verthein U, Degkwitz P, Haasen C, Krausz M: Significance of comorbidity for the long-term course of opiate dependence. Eur Addict Res 2005;11:15-21.
24. Joosen M, Garrity TF, Staton-Tindall M, Hiller ML, Leukefeld CG, Webster JM: Predictors of current depressive symptoms in a sample of drug court participants. Subst Use Misuse 2005;40:1113-1125.
25. Richter D, Eikelmann B, Berger K: Use of the SF-36 in the evaluation of a drug detoxification program. Qual Life Res 2004;13:907-914.
26. Fassino S, Daga GA, Delsedime N, Rogna L, Boggio S: Quality of life and personality disorders in heroin abusers. Drug Alcohol Depend 2004;76:73-80.
27. Kay JH, Altshuler LL, Ventura J, Mintz J: Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann Clin Psychiatry 1999;11:187-195.
28. Bernstein DP, Stein JA, Handelsman L: Predicting personality pathology among adult patients with substance use disorders: effects of childhood maltreatment. Addict Behav 1998;23:855-868.
29. Chen H, Cohen P, Crawford TN, Kasen S, Johnson JG, Berenson K: Relative impact of young adult personality disorders on subsequent quality of life: findings of a community-based longitudinal study. J Personal Disord 2006;20:510-523.
30. Black DW, Blum N, Letuchy E, Carney DC, Forman-Hoffman VL, Doebbeling BN: Borderline personality disorder and traits in veterans: psychiatric comorbidity, healthcare utilization, and quality of life along a continuum of severity. CNS Spectr 2006;11:680-689.
31. Cramer V, Torgersen S, Kringlen E: Personality disorders and quality of life. A population study. Compr Psychiatry 2006;47:178-184.
32. Lindstedt H, Soderlund A, Stalenheim G, Sjoden PO: Personality traits as predictors of occupational performance and life satisfaction among mentally disordered offenders. Nord J Psychiatry 2005;59:357-364.
33. Knight DK, Simpson DD: Influences of family and friends on client progress during drug abuse treatment. J Subst Abuse 1996;8:417-429.
34. Mallett S, Rosenthal D, Keys D: Young people, drug use and family conflict: pathways into homelessness. J Adolesc 2005;28:185-199.
35. Wiedemann G, Buchkremer G: Family therapy and work with relatives in various psychiatric diseases. Nervenarzt 1996;67:524-544.
36. Ryan CE: Clinical and research issues in the evaluation and treatment of families. Med Health R I 2002;85:278-280.
37. Leff J, Kuipers L, Berkowitz R, Sturgeon D: A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry 1985;146:594-600.
38. Dixon L, McFarlane WR, Lefley H, Lucksted A, Cohen M, Falloon I, Mueser K, Miklowitz D, Solomon P, Sondheimer D: Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatr Serv 2001;52:903-910.
39. Copello AG, Templeton L, Velleman R: Family interventions for drug and alcohol misuse: is there a best practice? Curr Opin Psychiatry 2006;19:271-276.
40. Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A: Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol 2000;61:916-919.
41. Gsellhofer B, Fahrner E-M: European Addiction Severity Index EuropASI. Manual für Training und Durchführung von Interviews mit dem EuropASI. München, IFT Institut für Therapieforschung, 1994.
42. Kokkevi A, Hartgers C: EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1995;1:208-210.
43. Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
44. Bullinger M: Assessment of health related quality of life with the SF-36 Health Survey. Rehabilitation (Stuttg) 1996;35:XVII-XXVII.
45. McHorney CA, Ware JEJ, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
46. Tunis SL, Johnstone BM, Gibson PJ, Loosbrock DL, Dulisse BK: Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia. J Clin Psychiatry 1999;60(suppl 19):38-45.
47. Hyler SE, Skodol AE, Oldham JM, Kellman HD, Doidge N: Validity of the Personality Diagnostic Questionnaire-Revised: a replication in an outpatient sample. Compr Psychiatry 1992;33:73-77.
48. Hyler SE, Skodol AE, Kellman HD, Oldham JM, Rosnick L: Validity of the Personality Diagnostic Questionnaire - revised: comparison with two structured interviews. Am J Psychiatry 1990;147:1043-1048.
49. Trull TJ, Widiger TA, Burr R: A structured interview for the assessment of the Five-Factor Model of personality: facet-level relations to the axis II personality disorders. J Pers 2001;69:175-198.
50. Uehara T, Sakado K, Sato T: Test-retest reliability of the Personality Diagnostic Questionnaire: revised. Psychiatry Clin Neurosci 1997;51:369-372.
51. Verheul R, van den Brink W, Hartgers C: Prevalence of personality disorders among alcoholics and drug addicts: an overview. Eur Addict Res 1995;1:166-177.
52. McKay JR: Is there a case for extended interventions for alcohol and drug use disorders? Addiction 2005;100:1594-1610.